Form 8-K - Current report:
SEC Accession No. 0001437749-25-011528
Filing Date
2025-04-09
Accepted
2025-04-09 16:31:59
Documents
15
Period of Report
2025-04-09
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20250408_8k.htm   iXBRL 8-K 20661
6 a01.jpg GRAPHIC 10221
  Complete submission text file 0001437749-25-011528.txt   189210

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20250409.xsd EX-101.SCH 3578
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20250409_def.xml EX-101.DEF 11806
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20250409_lab.xml EX-101.LAB 15857
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20250409_pre.xml EX-101.PRE 12021
17 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20250408_8k_htm.xml XML 2946
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 25825575
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)